Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1' H)-triones for treatment of conditions associated with vanilloid receptor 1
Details for Australian Patent Application No. 2007212786 (hide)
International Classifications
Event Publications
21 August 2008 PCT application entered the National Phase
PCT publication WO2007/091947 Priority application(s): WO2007/091947
6 May 2010 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the Name AstraZeneca AB, Application No. 2007212786, under INID (54) correct the title to read Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'H)-triones for treatment of conditions associated with vanilloid receptor 1
2 June 2011 Application Accepted
Published as AU-B-2007212786
29 September 2011 Standard Patent Sealed
30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007212804-A method and nodes for providing adaptive segmentation
2007212782-Device for filling of a container of collapsible type
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser